Elekta AB (OTCMKTS:EKTAY) Short Interest Down 53.3% in April

Elekta AB (OTCMKTS:EKTAY) saw a large drop in short interest in April. As of April 30th, there was short interest totaling 669 shares, a drop of 53.3% from the April 15th total of 1,433 shares. Based on an average daily trading volume, of 1,312 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.0% of the company’s shares are sold short.

Elekta Price Performance

Elekta stock opened at $5.83 on Friday. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.95 and a quick ratio of 0.73. The stock has a market cap of $2.15 billion, a price-to-earnings ratio of -582.02 and a beta of 1.01. The firm has a 50-day moving average of $6.00 and a two-hundred day moving average of $5.90. Elekta has a 1 year low of $4.35 and a 1 year high of $6.93.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Thursday, March 5th. The company reported $0.09 EPS for the quarter. The business had revenue of $433.29 million for the quarter. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%. On average, research analysts forecast that Elekta will post 0.39 earnings per share for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.